We’re glad to see you’re enjoying ReachMD…but how about a more personalized experience?
The Shifting ATTR-CM Landscape: Early Diagnosis, Emerging Therapies & Personalized Care
Pablo Garcia-Pavia, MD, PhD
Francesco Cappelli, MD
ns-MRAs: The Cardiovascular-Kidney-Metabolic Connection
Csaba P. Kovesdy, MD
Finnian R. Mc Causland, MD
ns-MRAs and eGFR Slope: The Kidney Perspective
Mastering MRA Monitoring: The Key to Success
Akshay S. Desai, MD
John McMurray, MD
Optimizing HF Outcomes Across the Spectrum: Emerging Evidence
MOA Deep Dive: The MRA Spectrum
Hiddo L. Heerspink, PhD
Emerging Evidence in HF Care
Pardeep Jhund, MD, PhD
Nonsteroidal MRAs: The CKD/T2D Advantage
Bridging the Gap: ns-MRAs in Cardiovascular-Kidney-Metabolic Syndrome Care
Nonsteroidal MRAs: The CKD/T1D Potential
The Next Generation of Risk Stratification in Patients With PH
Jean M. Elwing, MD
Richard N. Channick, MD
Victor Moles, MD
Update of ESC Guidelines on Heart Failure in a Nutshell
First ESC Guidelines on Cardiomyopathies - Diagnosis
Transformation of Treatment Strategies for ATTR Amyloidosis
First ESC Guidelines on Cardiomyopathies Management
Press cancel to remain on ReachMD. Press the link below or the continue button to keep going.
Stay current with the best on medical education